Volta Medical's RESTART Trial Shows Promising Findings for AI Solutions in Recurrent Atrial Fibrillation
17.03.2026 - 17:17:35 | prnewswire.co.uk
Volta Medical's artificial intelligence (AI) solution demonstrated 83% freedom from atrial fibrillation (AF) at 12 months after a single procedure in patients with recurrent AF and isolated pulmonary veins following prior ablationView original content:https://www.prnewswire.co.uk/news-releases/volta-medicals-restart-trial-shows-promising-findings-for-ai-solutions-in-recurrent-atrial-fibrillation-302676841.html
en | boerse | 68712161 |
